Booster dose for Indian medical device makers

The stipulation for US or European regulatory approval excludes local manufacturers from tenders and to level the playing field, it is recommended that there should be preference for Make in India products during public procurement, the Department of Pharmaceuticals said in a recent letter to the states

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2siDFph
via IFTTT